Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124168724 | 12416872 | 4 | F | 20160525 | 20160701 | 20160530 | 20160705 | EXP | US-AMGEN-USACT2016068533 | AMGEN | 5.00 | YR | C | F | Y | 21.00000 | KG | 20160705 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124168724 | 12416872 | 1 | PS | carfilzomib | CARFILZOMIB | 1 | Intravenous (not otherwise specified) | 16 MG, PER CHEMO REGIM | 202714 | 16 | MG | INTRAVENOUS INFUSION | |||||||
| 124168724 | 12416872 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 2.36-8 MG, UNK | 0 | ||||||||||
| 124168724 | 12416872 | 3 | SS | MITOXANTRONE | MITOXANTRONE HYDROCHLORIDE | 1 | Unknown | 8 MG, UNK | 0 | 8 | MG | ||||||||
| 124168724 | 12416872 | 4 | SS | PEG/L-ASPARAGINASE | PEGASPARGASE | 1 | Unknown | 800 UNK, UNK | 0 | ||||||||||
| 124168724 | 12416872 | 5 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | 1.2 MG, UNK | 0 | 1.2 | MG | ||||||||
| 124168724 | 12416872 | 6 | C | METHOTREXATE. | METHOTREXATE | 1 | 12 MG, UNK | 0 | 12 | MG | |||||||||
| 124168724 | 12416872 | 7 | C | PROPOFOL. | PROPOFOL | 1 | Intravenous (not otherwise specified) | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 124168724 | 12416872 | 8 | C | MICAFUNGIN | MICAFUNGIN | 1 | Intravenous (not otherwise specified) | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 124168724 | 12416872 | 9 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Oral | 200 MG, UNK | 0 | 200 | MG | ||||||||
| 124168724 | 12416872 | 10 | C | POLYSPORIN | BACITRACIN ZINCPOLYMYXIN B SULFATE | 1 | Topical | 10000 UNK, UNK | 0 | ||||||||||
| 124168724 | 12416872 | 11 | C | BIOTENE NOS | CETYLPYRIDINIUM CHLORIDE OR SODIUM FLUORIDE OR SODIUM MONOFLUOROPHOSPHATE OR GLUCOSE OXIDASELACTOFERRINLACTOPEROXIDASE BOVINELYSOZYME | 1 | 5 ML, UNK | 0 | 5 | ML | |||||||||
| 124168724 | 12416872 | 12 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | ||||||||
| 124168724 | 12416872 | 13 | C | CYTARABINE. | CYTARABINE | 1 | 0 | ||||||||||||
| 124168724 | 12416872 | 14 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 200 MG, UNK | 0 | 200 | MG | ||||||||
| 124168724 | 12416872 | 15 | C | CHLORHEXIDINE GLUCONATE. | CHLORHEXIDINE GLUCONATE | 1 | Topical | 1 UNK, UNK | 0 | ||||||||||
| 124168724 | 12416872 | 16 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 75 MG, UNK | 0 | 75 | MG | ||||||||
| 124168724 | 12416872 | 17 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | Oral | 4.25 G, UNK | 0 | 4.25 | G | ||||||||
| 124168724 | 12416872 | 18 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 56 MG, UNK | 0 | 56 | MG | ||||||||
| 124168724 | 12416872 | 19 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 4 MG, UNK | 0 | 4 | MG | ||||||||
| 124168724 | 12416872 | 20 | C | LORAZEPAM. | LORAZEPAM | 1 | Intravenous (not otherwise specified) | 0.5 MG, UNK | 0 | .5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124168724 | 12416872 | 1 | Acute lymphocytic leukaemia |
| 124168724 | 12416872 | 2 | Acute lymphocytic leukaemia |
| 124168724 | 12416872 | 3 | Acute lymphocytic leukaemia |
| 124168724 | 12416872 | 4 | Acute lymphocytic leukaemia |
| 124168724 | 12416872 | 5 | Acute lymphocytic leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124168724 | 12416872 | LT |
| 124168724 | 12416872 | OT |
| 124168724 | 12416872 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124168724 | 12416872 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124168724 | 12416872 | 1 | 20160509 | 0 | ||
| 124168724 | 12416872 | 2 | 20160509 | 20160603 | 0 | |
| 124168724 | 12416872 | 3 | 20160516 | 20160517 | 0 | |
| 124168724 | 12416872 | 4 | 20160518 | 20160602 | 0 | |
| 124168724 | 12416872 | 5 | 20160518 | 20160608 | 0 | |
| 124168724 | 12416872 | 6 | 20160516 | 20160516 | 0 | |
| 124168724 | 12416872 | 7 | 20160515 | 20160515 | 0 | |
| 124168724 | 12416872 | 8 | 20160511 | 0 | ||
| 124168724 | 12416872 | 9 | 20160516 | 0 | ||
| 124168724 | 12416872 | 10 | 20160522 | 0 | ||
| 124168724 | 12416872 | 11 | 20160511 | 0 | ||
| 124168724 | 12416872 | 12 | 20160511 | 20160519 | 0 | |
| 124168724 | 12416872 | 14 | 20160509 | 0 | ||
| 124168724 | 12416872 | 15 | 20160510 | 0 | ||
| 124168724 | 12416872 | 16 | 20160509 | 0 | ||
| 124168724 | 12416872 | 17 | 20160510 | 0 | ||
| 124168724 | 12416872 | 18 | 20151001 | 0 | ||
| 124168724 | 12416872 | 19 | 20160509 | 0 | ||
| 124168724 | 12416872 | 20 | 20160530 | 20160609 | 0 |